195 related articles for article (PubMed ID: 15188146)
1. Urothelial carcinoma of the urinary bladder with a component of acinar/tubular type differentiation simulating prostatic adenocarcinoma.
Huang Q; Chu PG; Lau SK; Weiss LM
Hum Pathol; 2004 Jun; 35(6):769-73. PubMed ID: 15188146
[TBL] [Abstract][Full Text] [Related]
2. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.
Gordetsky J; Epstein JI
Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758
[TBL] [Abstract][Full Text] [Related]
3. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
Osunkoya AO; Epstein JI
Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
[TBL] [Abstract][Full Text] [Related]
4. Clear cell urothelial carcinoma of the urinary bladder: a case report and review of the literature.
Knez VM; Barrow W; Lucia MS; Wilson S; La Rosa FG
J Med Case Rep; 2014 Aug; 8():275. PubMed ID: 25124389
[TBL] [Abstract][Full Text] [Related]
5. Colonic adenocarcinoma metastatic to the urinary tract versus primary tumors of the urinary tract with glandular differentiation: a report of 7 cases and investigation using a limited immunohistochemical panel.
Tamboli P; Mohsin SK; Hailemariam S; Amin MB
Arch Pathol Lab Med; 2002 Sep; 126(9):1057-63. PubMed ID: 12204054
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
[TBL] [Abstract][Full Text] [Related]
7. Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer.
Chan E; Garg K; Stohr BA
Mod Pathol; 2020 Sep; 33(9):1802-1810. PubMed ID: 32313185
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
Genega EM; Hutchinson B; Reuter VE; Gaudin PB
Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075
[TBL] [Abstract][Full Text] [Related]
9. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of immunohistochemistry in the diagnoses of urinary bladder neoplasia.
Hodges KB; Lopez-Beltran A; Emerson RE; Montironi R; Cheng L
Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):401-10. PubMed ID: 20505509
[TBL] [Abstract][Full Text] [Related]
11. Poorly differentiated adenocarcinomas of prostate versus high-grade urothelial carcinoma of the bladder: a diagnostic dilemma with immunohistochemical evaluation of 2 cases.
Martínez-Rodríguez M; Ramos D; Soriano P; Subramaniam M; Navarro S; Llombart-Bosch A
Int J Surg Pathol; 2007 Apr; 15(2):213-8. PubMed ID: 17478786
[TBL] [Abstract][Full Text] [Related]
12. Intravesical botryoid adenocarcinoma of the prostate: report of an unusual growth pattern of prostatic carcinoma simulating a urinary bladder tumor.
Camilot D; Pizzolitto S; DeMaglio G; Falconieri G
Ann Diagn Pathol; 2007 Dec; 11(6):413-6. PubMed ID: 18022125
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
Lane Z; Hansel DE; Epstein JI
Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
[TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma in ectopic prostatic tissue at dome of bladder: a case report of a patient with urothelial carcinoma of the bladder and adenocarcinoma of the prostate.
Gardner JM; Khurana H; Leach FS; Ayala AG; Zhai J; Ro JY
Arch Pathol Lab Med; 2010 Sep; 134(9):1271-5. PubMed ID: 20807045
[TBL] [Abstract][Full Text] [Related]
15. High molecular weight cytokeratin antibody (clone 34betaE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer.
Varma M; Morgan M; Amin MB; Wozniak S; Jasani B
Histopathology; 2003 Feb; 42(2):167-72. PubMed ID: 12558749
[TBL] [Abstract][Full Text] [Related]
16. Malignant glandular lesions and glandular differentiation in invasive/noninvasive urothelial carcinoma of the urinary bladder.
Behzatoğlu K
Ann Diagn Pathol; 2011 Dec; 15(6):422-6. PubMed ID: 21855380
[TBL] [Abstract][Full Text] [Related]
17. Urothelial-type adenocarcinoma of the prostate mimicking metastatic colorectal adenocarcinoma.
Adley BP; Maxwell K; Dalton DP; Yang XJ
Int Braz J Urol; 2006; 32(6):681-7; discussion 687-8. PubMed ID: 17201946
[TBL] [Abstract][Full Text] [Related]
18. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.
Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA
Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819
[TBL] [Abstract][Full Text] [Related]
19. Prostatic adenocarcinoma with urothelial (transitional cell) carcinoma features.
Mai KT; Collins JP; Veinot JP
Appl Immunohistochem Mol Morphol; 2002 Sep; 10(3):231-6. PubMed ID: 12373149
[TBL] [Abstract][Full Text] [Related]
20. Mucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging entity.
Curtis MW; Evans AJ; Srigley JR
Mod Pathol; 2005 Apr; 18(4):585-90. PubMed ID: 15778694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
